GLP-3 RT (10mg / vial) is a next-generation research peptide designed as a triple agonist targeting GLP-1, GIP, and glucagon receptors. This unique mechanism makes it one of the most promising compounds for comprehensive metabolic regulation, supporting blood sugar balance, appetite suppression, fat loss, and potential lean muscle preservation.

Originally investigated for type 2 diabetes and obesity, Retatrutide has shown powerful effects on weight reduction and metabolic health, often surpassing traditional GLP-1 agonists. By activating multiple metabolic pathways, it enhances energy expenditure, improves insulin sensitivity, and supports long-term body composition improvements.

FOR RESEARCH ONLY

FDA DISCLAIMER

The information provided on this website has not been evaluated by the U.S. Food and Drug Administration (FDA). None of the statements herein, nor any of the products offered, are intended to diagnose, treat, cure, or prevent any medical condition.

All products are supplied strictly as laboratory research reagents and are not for human consumption. We do not provide products to patients and do not make any claims regarding medical use.

PharmaPure Peptide operates solely as a chemical supplier. It is not a compounding pharmacy and does not operate as a compounding facility under Section 503A of the Federal Food, Drug, and Cosmetic Act.